Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism

  • Park, Ji Sook (Department of Pediatrics, Gyeongsang National Unviersity School of Medicine) ;
  • Lee, Hong-Jun (Department of Pediatrics, Gyeongsang National Unviersity School of Medicine) ;
  • Park, Chan-Hoo (Department of Pediatrics, Gyeongsang National Unviersity School of Medicine)
  • Received : 2014.08.21
  • Accepted : 2014.09.25
  • Published : 2016.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Congenital hyperinsulinism (CHI) is a rare condition that can cause irreversible brain damage during the neonatal period owing to the associated hypoglycemia. Hypoglycemia in CHI occurs secondary to the dysregulation of insulin secretion. CHI has been established as a genetic disorder of islet-cell hyperplasia, associated with a mutation of the ABCC8 or KCNJ11 genes, which encode the sulfonylurea receptor 1 and the inward rectifying potassium channel (Kir6.2) subunit of the ATP-sensitive potassium channel, respectively. We report the case of a female newborn infant who presented with repetitive seizures and episodes of apnea after birth, because of hypoglycemia. Investigations revealed hypoglycemia with hyperinsulinemia, but no ketone bodies, and a low level of free fatty acids. High dose glucose infusion, enteral feeding, and medications could not maintain the patient's serum glucose level. Genetic testing revealed a new variation of ABCC8 mutation. Therefore, we report this case of CHI caused by a novel mutation of ABCC8 in a half-Korean newborn infant with diazoxide-unresponsive hyperinsulinemic hypoglycemia.

Keywords

References

  1. Sperling MA. Hypoglycemia. In: Kliegman RM, Stanton BF, St. Geme JW III, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders, 2011:517-31.
  2. Park SE, Flanagan SE, Hussain K, Ellard S, Shin CH, Yang SW. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism. Eur J Endocrinol 2011;164:919-26. https://doi.org/10.1530/EJE-11-0160
  3. Ohkubo K, Nagashima M, Naito Y, Taguchi T, Suita S, Okamoto N, et al. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy. Clin Endocrinol (Oxf) 2005;62:458-65. https://doi.org/10.1111/j.1365-2265.2005.02242.x
  4. Biagiotti L, Proverbio MC, Bosio L, Gervasi F, Rovida E, Cerioni V, et al. Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy. Exp Mol Pathol 2007;83:59-64. https://doi.org/10.1016/j.yexmp.2006.11.006
  5. Hussain K. Congenital hyperinsulinism. Semin Fetal Neonatal Med 2005;10:369-76. https://doi.org/10.1016/j.siny.2005.03.001
  6. Bellanne-Chantelot C, Saint-Martin C, Ribeiro MJ, Vaury C, Verkarre V, Arnoux JB, et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet 2010;47:752-9. https://doi.org/10.1136/jmg.2009.075416
  7. Demirbilek H, Arya VB, Ozbek MN, Akinci A, Dogan M, Demirel F, et al. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations. Eur J Endocrinol 2014;170:885-92. https://doi.org/10.1530/EJE-14-0045
  8. Sandal T, Laborie LB, Brusgaard K, Eide SA, Christesen HB, Sovik O, et al. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clin Genet 2009;75:440-8. https://doi.org/10.1111/j.1399-0004.2009.01152.x
  9. Flanagan SE, Clauin S, Bellanne-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009;30:170-80. https://doi.org/10.1002/humu.20838
  10. James C, Kapoor RR, Ismail D, Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet 2009;46:289-99. https://doi.org/10.1136/jmg.2008.064337
  11. Yorifuji T. Congenital hyperinsulinism: current status and future perspectives. Ann Pediatr Endocrinol Metab 2014;19:57-68. https://doi.org/10.6065/apem.2014.19.2.57
  12. Shanbag P, Pathak A, Vaidya M, Shahid SK. Persistent hyperinsulinemic hypoglycemia of infancy----successful therapy with nifedipine. Indian J Pediatr 2002;69:271-2. https://doi.org/10.1007/BF02734240
  13. Bas F, Darendeliler F, Demirkol D, Bundak R, Saka N, Gunoz H. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 1999;12:873-8.
  14. Mazor-Aronovitch K, Landau H, Gillis D. Surgical versus non-surgical treatment of congenital hyperinsulinism. Pediatr Endocrinol Rev 2009;6:424-30.
  15. Veitia RA. Exploring the etiology of haploinsufficiency. Bioessays 2002;24:175-84. https://doi.org/10.1002/bies.10023